Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 13 04:00PM ET
16.10
Dollar change
-0.02
Percentage change
-0.12
%
Index- P/E- EPS (ttm)-19.13 Insider Own0.07% Shs Outstand1.32M Perf Week-3.62%
Market Cap21.32M Forward P/E- EPS next Y- Insider Trans- Shs Float1.32M Perf Month-0.92%
Income-23.82M PEG- EPS next Q- Inst Own51.34% Short Float1.70% Perf Quarter-1.04%
Sales20.87M P/S1.02 EPS this Y- Inst Trans295.63% Short Ratio1.03 Perf Half Y41.60%
Book/sh14.17 P/B1.14 EPS next Y- ROA-42.31% Short Interest0.02M Perf Year-16.15%
Cash/sh14.90 P/C1.08 EPS next 5Y- ROE-80.46% 52W Range6.20 - 22.32 Perf YTD10.58%
Dividend Est.- P/FCF- EPS past 5Y11.57% ROI-127.33% 52W High-27.87% Beta0.61
Dividend TTM- Quick Ratio3.95 Sales past 5Y15.45% Gross Margin94.47% 52W Low159.68% ATR (14)0.58
Dividend Ex-Date- Current Ratio3.95 EPS Y/Y TTM35.60% Oper. Margin-56.90% RSI (14)41.31 Volatility4.90% 3.11%
Employees50 Debt/Eq0.00 Sales Y/Y TTM-37.15% Profit Margin-114.11% Recom1.67 Target Price560.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-176.31% Payout- Rel Volume4.44 Prev Close16.12
Sales Surprise399.00% EPS Surprise131.91% Sales Q/Q-100.00% Earnings- Avg Volume21.87K Price16.10
SMA20-4.04% SMA50-3.56% SMA20016.99% Trades Volume97,177 Change-0.12%
Date Action Analyst Rating Change Price Target Change
Mar-13-20Upgrade Robert W. Baird Neutral → Outperform $5
Jul-30-19Downgrade Robert W. Baird Outperform → Neutral
May-14-19Initiated Robert W. Baird Outperform $5
Mar-19-18Initiated Jefferies Buy $12
Mar-19-18Initiated Evercore ISI Outperform $13
Jan-16-18Reiterated H.C. Wainwright Buy $9 → $12
May-30-17Initiated Rodman & Renshaw Buy $9
Aug-05-16Resumed ROTH Capital Buy
Aug-12-15Initiated JMP Securities Mkt Outperform
Jul-27-15Initiated Oppenheimer Outperform $8
Nov-13-24 04:53PM
Nov-07-24 08:30AM
Oct-17-24 07:30AM
Oct-15-24 07:30AM
Oct-03-24 07:30AM
07:11PM Loading…
Aug-14-24 07:11PM
Jul-24-24 06:30AM
Jul-08-24 08:15AM
May-17-24 02:52PM
May-15-24 05:43PM
Apr-19-24 12:10PM
Mar-27-24 08:00AM
Nov-14-23 05:36PM
Sep-25-23 12:00PM
Aug-24-23 12:32PM
12:00PM Loading…
Aug-23-23 12:00PM
Aug-17-23 08:00AM
Jul-19-23 02:02PM
08:40AM
Jul-18-23 01:59PM
09:15AM
Jul-17-23 07:29AM
Jun-23-23 10:50AM
Jun-21-23 07:00AM
Jun-11-23 10:28AM
Jun-02-23 04:30PM
May-22-23 08:00AM
May-21-23 08:00AM
May-15-23 06:07AM
May-11-23 01:41PM
08:15AM Loading…
May-10-23 08:15AM
07:00AM
May-05-23 06:41AM
May-04-23 08:00AM
May-02-23 04:30PM
Apr-17-23 08:00AM
Apr-01-23 12:47PM
Mar-31-23 06:10AM
Mar-29-23 05:00PM
08:35AM
07:00AM
Mar-24-23 05:00PM
Feb-19-23 07:39AM
Feb-14-23 05:40AM
Jan-17-23 07:10AM
Jan-10-23 08:00AM
Dec-21-22 06:01AM
Nov-23-22 08:00AM
Nov-09-22 08:00AM
Nov-02-22 08:35AM
07:00AM
Nov-01-22 09:15AM
Oct-26-22 08:00AM
Sep-12-22 08:03AM
Sep-08-22 04:01PM
Aug-24-22 10:34AM
08:00AM
Aug-10-22 06:20AM
Aug-04-22 02:03PM
09:35AM
07:00AM
Jul-28-22 07:20AM
Jul-14-22 06:29AM
Jun-02-22 08:00AM
May-18-22 09:35AM
08:00AM
May-16-22 09:35AM
08:29AM
May-11-22 08:45AM
07:00AM
May-04-22 08:00AM
Apr-15-22 11:00AM
Apr-09-22 06:00AM
Apr-08-22 06:15AM
Apr-05-22 12:00PM
Mar-04-22 04:00PM
Mar-01-22 11:05AM
07:00AM
Feb-28-22 09:25AM
Feb-23-22 08:00AM
Feb-04-22 08:58AM
Jan-28-22 08:00AM
Jan-27-22 06:23PM
Jan-16-22 10:30AM
Jan-14-22 08:00AM
Jan-03-22 07:00AM
Dec-15-21 12:53PM
Dec-06-21 09:33AM
Nov-11-21 08:05AM
Nov-08-21 08:00AM
Nov-02-21 09:05AM
07:00AM
Oct-26-21 08:00AM
Oct-14-21 10:00AM
Oct-06-21 08:00AM
Sep-09-21 08:00AM
Sep-08-21 10:31AM
Aug-27-21 10:40AM
Aug-24-21 09:00AM
Aug-06-21 09:42AM
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GERAGHTY JAMES ADirectorAug 07 '24Buy1.00111Oct 28 05:18 PM
ADAR1 Capital Management, LLC10% OwnerAug 12 '24Buy15.883,00047,647129,574Aug 12 06:48 PM
ADAR1 Capital Management, LLC10% OwnerAug 09 '24Buy14.893,00044,679127,331Aug 12 06:48 PM